7008 POSTER DISCUSSION Twenty-four-month Safety Data From...

7008 POSTER DISCUSSION Twenty-four-month Safety Data From Phase II Studies of Radium-223 Chloride, a First-in-class Alpha-pharmaceutical With a Highly Favorable Safety Profile for Patients With Castration-resistant Prostate Cancer (CRPC) and Bone Metastases

Nilsson, S., Haugen, I., Aksnes, A., O'Bryan-Tear, C.G., Parker, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71959-1
Date:
September, 2011
File:
PDF, 43 KB
english, 2011
Conversion to is in progress
Conversion to is failed